ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Gene therapy targets incurable diseases – Cronkite News

Cronkite NewsGene therapy targets incurable diseasesCronkite NewsPHOENIX — Gene therapy could be the key to curing rare and life-threatening diseases but potential negative effects and costs are slowing the fledgling field, experts say. Gene therapy re… Continue reading

2018-04-26 Michael Zand NEWS

NHS preparing to offer ‘game-changing’ cancer treatment – The Guardian

Continue reading

2018-04-26 Michael Zand NEWS

CRISPR/Cas9 silences gene associated with high cholesterol levels through epigenetic regulation – Phys.Org

CRISPR/Cas9 silences gene associated with high cholesterol levels through epigenetic regulationPhys.OrgAs researchers develop new ways to use the CRISPR/Cas9 for therapy and research, more information is emerging on how the immune system of living orga… Continue reading

2018-04-26 Michael Zand NEWS

Home Tests in Mind, Doudna Startup Races Rivals in CRISPR Diagnostics – Xconomy

XconomyHome Tests in Mind, Doudna Startup Races Rivals in CRISPR DiagnosticsXconomyAnother name for Cas12 is Cpf1, which Zhang and several others first characterized in a publication in 2015. Months later Editas Medicine (NASDAQ: EDIT), of which Zhang … Continue reading

2018-04-26 Michael Zand NEWS

Pioneering cancer therapy to be made available to NHS patients – AOL UK


The Guardian

NHS preparing to offer ‘game-changing’ cancer treatment
The Guardian
The treatments, which are hugely expensive, work by genetically engineering the patient’s immune system’s killer T–cells to recognise and destroy cancer cells. In trials, they have had extraordinary success, putting into remission patients who had only …
NHS set to offer cancer patients a ‘game changer’ treatment that could save THOUSANDS of livesDaily Mail
Pioneering cancer therapy to be made available to NHS patientsThe Irish News

all 4 news articles »

Continue reading

2018-04-26 Michael Zand NEWS

Bridged nucleic acids in CRISPR RNAs improves CRISPR gene … – Next Big Future

Next Big FutureBridged nucleic acids in CRISPR RNAs improves CRISPR gene …Next Big FutureCanadian research (Alberta) shows that the use of bridged nucleic acids to guide Cas9 can improve its specificity by over 10,000 times in certain instances — a d… Continue reading

2018-04-26 Michael Zand NEWS

The IO Movement: Priming the Immune System to Fight Cancer – Part I: Chimeric Antigen Receptor T (CAR-T) Cell … – Lexology

LexologyThe IO Movement: Priming the Immune System to Fight Cancer – Part I: Chimeric Antigen Receptor T (CAR-T) Cell …LexologyThis is the first article in a Series focused on current trends in immuno-oncology (I-O) and immunotherapy. Since the latte… Continue reading

2018-04-26 Michael Zand NEWS

UConn Health, Connecticut Children’s, to Host First Gene Therapy Trial for GSD – UConn Today


AOL UK

Pioneering cancer therapy to be made available to NHS patients
AOL UK
A charity has welcomed news that a pioneering therapy that uses a patient’s own genetically modified cells to fight cancer will be made available to NHS patients. Chimeric antigen receptor T–cell therapy (CAR-T) will be “one of the most innovative …
New CAR-T therapy could provide safer, more effective cancer …Brinkwire (press release)

all 3 news articles »

Continue reading

2018-04-26 Michael Zand NEWS
  • 1
  • …
  • 188
  • 189
  • 190
  • 191
  • 192
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

UConn Today

UConn Health, Connecticut Children’s, to Host First Gene Therapy Trial for GSD
UConn Today
A ground-breaking clinical trial focusing on Glycogen Storage Disease (GSD) Type Ia will be hosted by the GSD Program at Connecticut Children’s Medical Center and UConn Health, under the direction of pediatric endocrinologist and scientist Dr. David …

and more »